Study to Compare Pharmacokinetics and Safety of CT-P52 and US-licensed Taltz in Healthy Subjects
Clinical trial NCT07200986 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07200986
- Sponsor
- Celltrion
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-17
- Primary completion
- 2026-03-31
- Enrollment
- 218
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.